Expression of EGFR, PD-L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma.

Ilias P NikasSoo-Young ParkMin Ji SongCheol LeeHan-Suk Ryu

Published in: Diagnostic cytopathology (2023)

Measuring biomarkers using CBs from malignant effusions may provide clinicians with significant information related to HGSC prognosis and therapy selection, especially in patients with resistance to chemotherapy.

Keyphrases

high grade
low grade
small cell lung cancer
squamous cell carcinoma
poor prognosis
epidermal growth factor receptor
palliative care
stem cells
tyrosine kinase
healthcare
locally advanced
radiation therapy
bone marrow
mesenchymal stem cells
cell therapy